Form Comparison

Berberine HCl vs Dihydroberberine

Q: What is the difference between Berberine HCl and Dihydroberberine?

Berberine HCl has low absorption and low cost; dihydroberberine has variable absorption and high cost. Choose berberine HCl when cost matters most and you can split 1500 mg a day across meals; choose dihydroberberine when you want better absorption than berberine HCl with fewer GI side effects.

How berberine HCl and dihydroberberine differ in potency, absorption, tolerance, and cost.

This page contains affiliate links. Titrate earns a small commission when you purchase through them, at no cost to you. This does not affect our recommendations.

Quick verdict. Dihydroberberine absorbs better than berberine HCl and is the better starting point. Berberine HCl is the form behind most published glucose and lipid trials, but its oral bioavailability is poor: metabolic effects need about 1500 mg a day split across meals, and GI side effects are common at that dose. Dihydroberberine converts back to berberine after absorption, works at 100-200 mg, and causes fewer GI effects; its absorption data come from a small maker-funded pilot and it has no outcome trials, but the pharmacokinetic rationale is sound.

Side by Side

	Berberine HCl	Dihydroberberine
Absorption	Low	Variable
How it is absorbed	Poorly absorbed and pumped back into the gut lumen by P-glycoprotein; oral bioavailability was below 1% in rats. Part of its metabolic effect may begin in the gut.	A reduced form converted back to berberine after absorption. A five-person crossover pilot found higher plasma berberine from 100-200 mg than from 500 mg berberine HCl.
Typical dose	500 mg 2-3 times daily with meals	100-200 mg 1-2 times daily
Common uses	type 2 diabetes, LDL cholesterol, PCOS	glucose control
Side effects	Constipation, diarrhea, cramping, bloating.	GI effects appear milder at the lower doses used; human data are minimal.
Cost	Low	High
Also called	berberine hydrochloride	DHB, GlucoVantage

When to Choose Berberine HCl

Choose berberine HCl when cost matters most and you can split 1500 mg a day across meals. A lipid-matrix or dihydroberberine form absorbs better. The form used in nearly all of the glucose and lipid trials. Splitting the dose across meals improves GI tolerance.

Berberine HCl

The form used in most published trials, but oral bioavailability is poor. High doses (1500 mg/day) are needed for metabolic effects, and GI side effects are common at that level. Consider a lipid-matrix or DHB formulation first.

What to look for: If using this form, split the dose (500 mg three times daily with meals). Third-party tested.

Find on iHerb Affiliate link

When to Choose Dihydroberberine

Choose dihydroberberine when you want better absorption than berberine HCl with fewer GI side effects. No outcome trials. The absorption advantage rests on a pilot study funded by the ingredient's maker.

Dihydroberberine

A metabolite with better absorption than standard berberine HCl. Fewer GI side effects. Less clinical data than standard berberine but the pharmacokinetic rationale is sound.

What to look for: GlucoVantage is the branded form. Typical dose 100-200 mg, not directly comparable to berberine HCl milligram for milligram.

Find on iHerb Affiliate link

Products on Titrate

710 of the 214,745 labels in the NIH Dietary Supplement Label Database list berberine as an active ingredient (409 on market). 325 are sold as berberine products by name.

Open supplement search

Berberine does not have its own search category yet. Each product above links to its full label in the NIH database.

References

National Center for Complementary and Integrative Health. Goldenseal.

Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344-1351.

Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256-2264.

Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717.

Chen W, Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011;12(2):705-711.

Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217.

Hu Y, Ehli EA, Kittelsrud J, et al. Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine. 2012;19(10):861-867.

Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69-81.

Moon JM, Ratliff KM, Hagele AM, et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: a randomized, controlled, crossover pilot trial. Nutrients. 2021;14(1):124.